* HFTX Masters Academy Scientific Program - Afternoon Course


 
NOTE: This is the scientific program for the afternoon course. The identical course will be offered in the morning from 8am-1pm.
 

2:00 PM – 2:05 PM

WELCOME AND OVERVIEW
Daniel F. Dilling, MD, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA
Miranda Paraskeva, MBBS, Alfred Hospital, Melbourne, VC, Australia
 

2:05 PM –&dnash; 3:10 PM

SMALL GROUP INTERACTIVE DISCUSSION A: COMPLEX INFECTIONS
Moderator:
Amparo Sole, MD, PhD, Hospital Universitario la Fe Unidad de Transplante Pulmonar, Valencia Spain
 

2:05 PM

Summary of the state of the science of the session topic and the most pressing challenges relevant to the session topic
Amparo Sole, MD, PhD, Hospital Universitario la Fe Unidad de Transplante Pulmonar, Valencia, Spain
 

2:10 PM

CASE SCENARIO A1: M. abscessus Infection Management Pre- and Post-transplant in a CF Patient
Amparo Sole, MD, PhD, Hospital Universitario la Fe Unidad de Transplante Pulmonar, Valencia, Spain
 

2:40 PM

CASE SCENARIO A2: Mold Infection (non Aspergillus) in the Early Post-Lung Tansplant Period (Scedosporium or Mucor or Fusarium): A Lung Transplant Recipient with Disseminated Infection
Shahid Husain, MD, MS, Toronto General Hospital, Toronto, Canada
 

3:10 PM – 4:15 PM

SMALL GROUP INTERACTIVE DISCUSSION B: AIRWAY COMPLICATIONS
Moderator:
Aleem Siddique, MBBS, University of Nebraska Medical Center, Omaha, NE, USA
 

3:10 PM

Summary of the state of the science of the session topic and the most pressing challenges relevant to the session topic
Aleem Siddique, MBBS, University of Nebraska Medical Center, Omaha, NE, USA
 

3:15 PM

CASE SCENARIO B1: Necrosis and Dehiscence of the Airway 4 Weeks after Lung Transplant in a Recipient with Cystic Fibrosis
Aleem Siddique, MBBS, University of Nebraska Medical Center, Omaha, NE, USA
 

3:45 PM

CASE SCENARIO B2: Bronchial Stenosis 5 Months after Lung Transplant in a Patient with Idiopathic Pulmonary Fibrosis
Maria Crespo, MD, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
 

4:15 PM – 4:45 PM

COFFEE BREAK
 

4:45 PM – 5:50 PM

SMALL GROUP INTERACTIVE DISCUSSION C: FRAILTY
Moderator:
Michelle Murray, MD, MSc, MRCPI, Mater Misericordiae University Hospital, Dublin, Ireland
 

4:45 PM

Summary of the state of the science of the session topic and the most pressing challenges relevant to the session topic
Michelle Murray, MD, MSc, MRCPI, Mater Misericordiae University Hospital, Dublin, Ireland
 

4:50 PM

CASE SCENARIO C1: A 35 year-old Patient with Cystic Fibrosis Referred for Lung Transplantation
Michelle Murray, MD, MSc, MRCPI, Mater Misericordiae University Hospital, Dublin, Ireland
 

5:20 PM

CASE SCENARIO C2: A 65 year-old Patient with IPF Referred for Lung Transplantation
Jonathan Singer, MD, University of California San Francisco, San Francisco, CA, USA
 

5:50 PM – 6:55 PM

SMALL GROUP INTERACTIVE DISCUSSION D: EX-VIVO LUNG PERFUSION (EVLP)
Moderator: 
Marcelo Cypel, MD, Toronto General Hospital, Toronto, Canada
 

5:50 PM

Summary of the state of the science of the session topic and the most pressing challenges relevant to the session topic
Marcelo Cypel, MD, Toronto General Hospital, Toronto, Canada
 

5:55 PM

CASE SCENARIO D1: A Case of a Patient Desperate for a Transplant, a Donor Presents with Low p/f Ratio and Evidence of Edema that Improves after EVLP
Marcelo Cypel, MD, Toronto General Hospital, Toronto, Canada
 

6:25 PM

CASE SCENARIO D2: A Case of Donor Lungs Retrieved using Portable EVLP from a Distant Location Allowing for Successful Lung Transplantation
Dirk Van Raemdonck, MD, University of Leuven, Leuven, Belgium
 

6:55 PM   7:00 PM

CLOSING REMARKS
Daniel F. Dilling, MD, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA
Miranda Paraskeva, MBBS, Alfred Hospital, Melbourne, Australia
 

1:00 PM

ADJOURN



*This scientific program is updated each Friday to reflect any changes in information, including room names, session times, speaker information